The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia
Open accessAbstract
The balance between bioactivation and degradation of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] is critical for ensuring appropriate biological effects of vitamin D. Cytochrome P450, family 24-mediated (CYP24-mediated) 24-hydroxylation of 1,25(OH)2D3 is an important step in the catabolism of 1,25(OH)2D3. The enzyme is directly regulated by vitamin D receptor (VDR), and it is expressed mainly in the kidney, where VDR is also abundant. A recent report suggests that activation of steroid and xenobiotic receptor (SXR) also enhances the expression of CYP24, providing a new molecular mechanism of drug-induced osteomalacia. However, here we showed that activation of SXR did not induce CYP24 expression in vitro and in vivo, nor did it transactivate the CYP24 promoter. Instead, SXR inhibited VDR-mediated CYP24 promoter activity, and CYP24 expression was very low in tissues containing high levels of SXR, including the small intestine. Moreover, 1,25(OH)2D3-induced CYP24 expression was enhanced in mice lacking the SXR ortholog pregnane X receptor, and treatment of humans with the SXR agonist rifampicin had no effect on intestinal CYP24 expression, despite demonstration of marked CYP3A4 induction. Combined with our previous findings that CYP3A4, not CYP24, plays the dominant role in hydroxylation of 1,25(OH)2D3 in human liver and intestine, our results indicate that SXR has a dual role in mediating vitamin D catabolism and drug-induced osteomalacia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Norman, A. W. (1979) · Cited by 3,769
Umesono, K., Murakami, K. K., Thompson, C. C., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90020-y · Cited by 1,716
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
Current Understanding of the Molecular Actions of Vitamin D
JONES, G., STRUGNELL, S. A., & DeLUCA, H. F. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.1193 · Cited by 1,274
Structure-Function Relationships in the Vitamin D Endocrine System*
BOUILLON, R., OKAMURA, W. H., & NORMAN, A. W. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-200 · Cited by 1,235
Noncalcemic Actions of Vitamin D Receptor Ligands
Nagpal, S., Na, S., & Rathnachalam, R. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0002 · Cited by 961
The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism
Kliewer, S. A., Goodwin, B., & Willson, T. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0038 · Cited by 921
SXR, a novel steroid and xenobioticsensing nuclear receptor
Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3195 · Cited by 919
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux
Synold, T. W., Dussault, I., & Forman, B. M. (2001) · Nature Medicine · doi:10.1038/87912 · Cited by 840
Humanized xenobiotic response in mice expressing nuclear receptor SXR
Xie, W., Barwick, J. L., Downes, M., Blumberg, B., Simon, C. M., Nelson, M. C., Neuschwander-Tetri, B. A., Brunt, E. M., Guzelian, P. S., & Evans, R. M. (2000) · Nature · doi:10.1038/35019116 · Cited by 660
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
25-Hydroxyvitamin D 3 1α-Hydroxylase and Vitamin D Synthesis
Takeyama, K.-I., Kitanaka, S., Sato, T., Kobori, M., Yanagisawa, J., & Kato, S. (1997) · Science · doi:10.1126/science.277.5333.1827 · Cited by 538
Willson, T. M., & Kliewer, S. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd753 · Cited by 503
Vitamin K2 Regulation of Bone Homeostasis Is Mediated by the Steroid and Xenobiotic Receptor SXR
Tabb, M. M., Sun, A., Zhou, C., Grün, F., Errandi, J., Romero, K., Pham, H., Inoue, S., Mallick, S., Lin, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303136200 · Cited by 387
Self-citationDrocourt, L., Ourlin, J.-C., Pascussi, J.-M., Maurel, P., & Vilarem, M.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201323200 · Cited by 356
Transcriptional Control of Intestinal Cytochrome P-4503A by 1α,25-Dihydroxy Vitamin D3
Thummel, K. E., Brimer, C., Yasuda, K., Thottassery, J., Senn, T., Lin, Y., Ishizuka, H., Kharasch, E., Schuetz, J., & Schuetz, E. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1399 · Cited by 325
Mechanisms of gene regulation by vitamin D3 receptor: a network of coactivator interactions
Rachez, C., & Freedman, L. P. (2000) · Gene · doi:10.1016/s0378-1119(00)00052-4 · Cited by 323
Possible involvement of pregnane X receptor–enhanced CYP24 expression in drug-induced osteomalacia
Pascussi, J., Robert, A., Nguyen, T. M., Walrant-Debray, O., Garabédian, M., Martin, P. G. P., Pineau, T., Saric, J., Navarro, F., Maurel, P., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200521867 · Cited by 317
Vitamin D: More Than a “Bone-a-Fide” Hormone
Sutton, A. L. M., & MacDonald, P. N. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0363 · Cited by 294
Antiepileptic Drug–Induced Bone Loss in Young Male Patients Who Have Seizures
Andress, D. L. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.781 · Cited by 205
Kim, S., Shevde, N. K., & Pike, J. W. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041112 · Cited by 196
Xu, Y., Hashizume, T., Shuhart, M. C., Davis, C. L., Nelson, W. L., Sakaki, T., Kalhorn, T. F., Watkins, P. B., Schuetz, E. G., & Thummel, K. E. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.017392 · Cited by 173
Structural basis of VDR–DNA interactions on direct repeat response elements
Shaffer, P. L., & Gewirth, D. T. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2242 · Cited by 157
Epilepsy and bone health in adults
Pack, A. M., & Morrell, M. J. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.11.029 · Cited by 150
Rodan, G. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13361 · Cited by 148
Miki, Y., Suzuki, T., Tazawa, C., Blumberg, B., & Sasano, H. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.12.005 · Cited by 145
Dotzlaw, H., Leygue, E., Watson, P. H., & Murphy, L. C. (1999) · PubMed · Cited by 140
Zhou, C., Tabb, M. M., Sadatrafiei, A., Grün, F., & Blumberg, B. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000299 · Cited by 123
Self-citationZierold, C., Mings, J. A., & DeLuca, H. F. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10341 · Cited by 122
Kerry, D. M., Dwivedi, P. P., Hahn, C. N., Morris, H. A., Omdahl, J. L., & May, B. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29715 · Cited by 121
Yamamoto, H., Shevde, N. K., Warrier, A., Plum, L. A., DeLuca, H. F., & Pike, J. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304737200 · Cited by 90
Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice†
Saini, S. P. S., Mu, Y., Gong, H., Toma, D., Uppal, H., Ren, S., Li, S., Poloyac, S. M., & Xie, W. (2005) · Hepatology · doi:10.1002/hep.20570 · Cited by 85
Carlberg, C., & Seuter, S. (2007) · Dermatologic Clinics · doi:10.1016/j.det.2007.06.004 · Cited by 81
Inouye, K., & Sakaki, T. (2001) · Biotechnology annual review · doi:10.1016/s1387-2656(01)07037-5 · Cited by 64
Pharmaceutical use of mouse models humanized for the xenobiotic receptor
Xie, W., & Evans, R. M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02251-1 · Cited by 53
Grün, F., Venkatesan, R. N., Tabb, M. M., Zhou, C., Cao, J., Hemmati, D., & Blumberg, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206553200 · Cited by 50
Self-citationZhou, C., Tabb, M. M., Sadatrafiei, A., GR�N, F., Sun, A., & Blumberg, B. (2004) · Journal of Clinical Immunology · doi:10.1007/s10875-004-6248-z · Cited by 38
Self-citationThe Influence of Phenobarbital on Biotransformation of 25‐Hydroxycholecalciferol
Burt, R. W., Freston, J. W., & Tolman, K. G. (1976) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1976.tb02413.x · Cited by 13
Cited by
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., & Weaver, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0385 · Cited by 10,538
Vitamin D deficiency: a worldwide problem with health consequences
Holick, M. F., & Chen, T. C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.1080s · Cited by 2,689
Rosen, C. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1009570 · Cited by 816
Vitamin D: The "sunshine" vitamin.
(2012) · Europe PMC (PubMed Central) · doi:10.4103/0976-500x.95506 · Cited by 652
Metadata
- Authors
- Zhou, C.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-06-01
- Volume
- 116
- Issue
- 6
- Pages
- 1703-1712
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2135618285
- Cited by
- 256
- References
- 41
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.